Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

The high cost of celiac disease in an Israeli Health Maintenance Organization.

Heymann AD, Leshno M, Endevelt R, Shamir R.

Health Econ Rev. 2013 Nov 7;3(1):23. doi: 10.1186/2191-1991-3-23.

2.

Diagnostic accuracy of a new point-of-care screening assay for celiac disease.

Benkebil F, Combescure C, Anghel SI, Besson Duvanel C, Schäppi MG.

World J Gastroenterol. 2013 Aug 21;19(31):5111-7. doi: 10.3748/wjg.v19.i31.5111.

3.

Point-of-care testing for coeliac disease: primary care diagnostic technology update.

Khangura J, Van den Bruel A, Perera R, Heneghan C, Price CP, Wolstenholme J, Thompson M, Plüddemann A.

Br J Gen Pract. 2013 Jun;63(611):e426-8. doi: 10.3399/bjgp13X668401. No abstract available.

4.

Diagnosis of celiac disease.

Lebwohl B, Rubio-Tapia A, Assiri A, Newland C, Guandalini S.

Gastrointest Endosc Clin N Am. 2012 Oct;22(4):661-77. doi: 10.1016/j.giec.2012.07.004. Epub 2012 Aug 20. Review.

5.

Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study.

Ukkola A, Kurppa K, Collin P, Huhtala H, Forma L, Kekkonen L, Mäki M, Kaukinen K.

BMC Gastroenterol. 2012 Sep 27;12:136. doi: 10.1186/1471-230X-12-136.

6.

A gluten-free diet effectively reduces symptoms and health care consumption in a Swedish celiac disease population.

Norström F, Sandström O, Lindholm L, Ivarsson A.

BMC Gastroenterol. 2012 Sep 17;12:125. doi: 10.1186/1471-230X-12-125.

7.

Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis.

Violato M, Gray A, Papanicolas I, Ouellet M.

PLoS One. 2012;7(7):e41308. doi: 10.1371/journal.pone.0041308. Epub 2012 Jul 17.

8.

Sex and racial disparities in duodenal biopsy to evaluate for celiac disease.

Lebwohl B, Tennyson CA, Holub JL, Lieberman DA, Neugut AI, Green PH.

Gastrointest Endosc. 2012 Oct;76(4):779-85. doi: 10.1016/j.gie.2012.05.011. Epub 2012 Jun 23.

9.

Burden of celiac disease in the Mediterranean area.

Greco L, Timpone L, Abkari A, Abu-Zekry M, Attard T, Bouguerrà F, Cullufi P, Kansu A, Micetic-Turk D, Mišak Z, Roma E, Shamir R, Terzic S.

World J Gastroenterol. 2011 Dec 7;17(45):4971-8. doi: 10.3748/wjg.v17.i45.4971.

10.

Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.

Sharaiha RZ, Lebwohl B, Reimers L, Bhagat G, Green PH, Neugut AI.

Cancer. 2012 Aug 1;118(15):3786-92. doi: 10.1002/cncr.26700. Epub 2011 Dec 13.

11.

Autoimmunity: Celiac disease in T1DM-the need to look long term.

Rewers M, Eisenbarth GS.

Nat Rev Endocrinol. 2011 Nov 8;8(1):7-8. doi: 10.1038/nrendo.2011.193.

12.

The economics of coeliac disease: a population-based study.

Long KH, Rubio-Tapia A, Wagie AE, Melton LJ 3rd, Lahr BD, Van Dyke CT, Murray JA.

Aliment Pharmacol Ther. 2010 Jul;32(2):261-9. doi: 10.1111/j.1365-2036.2010.04327.x. Epub 2010 Apr 8.

Supplemental Content

Support Center